Bitrobius Genetics is developing the Gentrafix™ platform to solve the major problem with gene therapy: the inability of therapeutic genes to reach most of the cells in an affected organ or tissue. It promises to revolutionise the treatment of genetic diseases.
| Website | http://www.bitrobius.com |
| Employees | 6 (4 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Gene Therapy, Genetic Diseases, Genetic Engineering, Gene Editing, Drug Delivery, Precision Medicine, Genomics, Cell Therapy, Therapeutics, Personalized Medicine, Biotechnology, Pharmaceutical, Molecular Biology, Regenerative Medicine, Biomedical Research, Biopharma, Medical Technology, Clinical Trials, Healthcare |
| Competitors | Thermo Fisher Scientific, Regeneron, Illumina, GRAIL, Myriad Genetics, GeneDx, Veracyte, Inc., PacBio, Color, 23andMe Inc +40 more (view full list) |
Looking for a particular Bitrobius Genetics employee's phone or email?
Bitrobius Genetics Questions
Rocky Cranenburgh is the Chief Executive Officer and Founder of Bitrobius Genetics.
4 people are employed at Bitrobius Genetics.
Top Bitrobius Genetics Employees
-
Steven Powell
Non Executive Director at Bitrobius Genetics
United Kingdom12 -
1
-
1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
